SCHEMBL19735523

SCHEMBL19735523

c1ccc(-c2ccc(N(c3ccc(C4(c5ccccc5)c5ccccc5C5(c6ccccc6)c6ccccc6-c6cccc4c65)cc3)c3ccc4oc5ccccc5c4c3)cc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
OPRK1 P41145 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
ALOX5 P09917 1/20 0.31
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30
PLA2G10 O15496 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19735455 0.96 KDM4E (0.30) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL19735525 0.95 KDM4E (0.34) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL18326152 0.95 SMN1; SMN2 (0.35) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL17126376 0.95 SMN1; SMN2 (0.35) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL19735711 0.94 AHR (0.30) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL19735536 0.94 PLA2G2A (0.33) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL18326153 0.94 PLA2G2A (0.36) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL18073303 0.94 KDM4E (0.34) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL17804767 0.93 KDM4E (0.34) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL19735456 0.92 KDM4E (0.33) KDM4EMEN1MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3369719-B1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEMICAL LTD (KR) 2020-02-26 EP disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 US disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, NR2E3, LEF1 KDM4E 3359/4885MEN1 426/4885MAPT 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.